Investors Back Microbial Specialist EnteroBiotix’s Series A Financing
Microbiome-Based Portfolio Underpinned By End-To-End Control Of Supply Chain
Emerging Company Profile: Scotland-based EnteroBiotix will use proceeds from a successful series A financing to advance its nascent pipeline of novel high-diversity microbial therapeutics, enhancing the gut microbiome and eventually targeting multiple indications.
